203 related articles for article (PubMed ID: 6169172)
1. Platelet activation in myeloproliferative disorders.
Cortelazzo S; Viero P; Barbui T
Thromb Haemost; 1981 Jun; 45(3):211-3. PubMed ID: 6169172
[TBL] [Abstract][Full Text] [Related]
2. Does the beta TG/PF4 ratio have any value in myeloproliferative diseases?
Viero P; Cortelazzo S; Barbui T
Thromb Haemost; 1984 Jul; 51(3):411. PubMed ID: 6208631
[No Abstract] [Full Text] [Related]
3. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
Lane DA; Ireland H; Wolff S; Ranasinghe E; Dawes J
Thromb Haemost; 1984 Oct; 52(2):183-7. PubMed ID: 6084323
[TBL] [Abstract][Full Text] [Related]
4. The value of beta TG/PF4 ratio in patients with high platelet count.
Fabris F; Luzzatto G; Girolami A
Thromb Haemost; 1985 Apr; 53(2):288-9. PubMed ID: 2410998
[No Abstract] [Full Text] [Related]
5. Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases.
Viero P; Cortelazzo S; Bassan R; Barbui T
Thromb Haemost; 1982 Oct; 48(2):125-6. PubMed ID: 6184841
[TBL] [Abstract][Full Text] [Related]
6. In vivo platelet release in myeloproliferative disorders.
Ireland H; Lane DA; Wolff S; Foadi M
Thromb Haemost; 1982 Aug; 48(1):41-5. PubMed ID: 6215739
[TBL] [Abstract][Full Text] [Related]
7. Platelet activation in response to phlebotomy. An experimental study of healthy blood donors.
Eriksson KA; Sigvaldason A; Lindholm A; Safai-Kutti S; Kutti J
Acta Med Scand; 1982; 212(3):121-3. PubMed ID: 6183925
[TBL] [Abstract][Full Text] [Related]
8. [Selected parameters of blood platelet function in patients with myeloproliferative syndrome].
Zuk E
Ann Acad Med Stetin; 1998; 44():137-54. PubMed ID: 9857536
[TBL] [Abstract][Full Text] [Related]
9. Plasma and platelet beta-thromboglobulin in chronic myeloproliferative disorders.
Endo Y; Mamiya S; Satoh M
Nihon Ketsueki Gakkai Zasshi; 1981 Feb; 44(1):118-23. PubMed ID: 6171982
[No Abstract] [Full Text] [Related]
10. Platelet function studies in myeloproliferative disorders.
Pfliegler G; Boda Z; Udvardy M; Kiss A; Telek B; Pecze K; Nagy P; Rak K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):655-62. PubMed ID: 2435631
[TBL] [Abstract][Full Text] [Related]
11. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
Tomura S; Ida T; Kuriyama R; Chida Y; Takeuchi J; Motomiya T; Yamazaki H
Clin Nephrol; 1982 Jan; 17(1):24-30. PubMed ID: 6459902
[TBL] [Abstract][Full Text] [Related]
12. Platelet hyperfunction in patients with chronic airways obstruction.
Cordova C; Musca A; Violi F; Alessandri C; Perrone A; Balsano F
Eur J Respir Dis; 1985 Jan; 66(1):9-12. PubMed ID: 2579841
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of various parameters of platelet function in subjects with type II diabetes mellitus. Methodologic study of the changes in PF4 and beta-TG].
Ferri GM; Afeltra A; Caccavo D; Amoroso A
Recenti Prog Med; 1986 Jan; 77(1):31-2. PubMed ID: 2422709
[No Abstract] [Full Text] [Related]
14. Enhanced "in vitro" release of platelet alpha-granules after acute myocardial infarction (AMI).
Pengo V; Boschello M; Prandoni P; Schiavon R; Bellotto F; Schivazappa L; Dalla Volta S
Thromb Haemost; 1985 Aug; 54(2):544-6. PubMed ID: 2934859
[TBL] [Abstract][Full Text] [Related]
15. Defective platelet beta-N-acetyl hexosaminidase content and release in chronic myeloproliferative disorders.
Emiliani C; Ciferri S; Mencarelli S; Mezzasoma AM; Momi S; Orlacchio A; Gresele P
Platelets; 2006 Feb; 17(1):20-9. PubMed ID: 16308183
[TBL] [Abstract][Full Text] [Related]
16. [Clinical applications of beta-thromboglobulin and platelet factor 4 radioimmune assays (author's transl)].
Lokiec F; Najean Y
Nouv Presse Med; 1980 Oct; 9(38):2833-4, 2837-8. PubMed ID: 6160454
[TBL] [Abstract][Full Text] [Related]
17. Increased platelet activity in patients with isolated coronary artery ectasia.
Yasar AS; Erbay AR; Ayaz S; Turhan H; Metin F; Ilkay E; Sabah I
Coron Artery Dis; 2007 Sep; 18(6):451-4. PubMed ID: 17700216
[TBL] [Abstract][Full Text] [Related]
18. Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders.
Malpass TW; Savage B; Hanson SR; Slichter SJ; Harker LA
J Lab Clin Med; 1984 Jun; 103(6):894-904. PubMed ID: 6233383
[TBL] [Abstract][Full Text] [Related]
19. Platelet alpha-granule release in chronic myeloproliferative disorders with thrombocytosis.
Sacchi S; Curci G; Piccinini L; Messerotti A; Cucci F; Bursi R; Zaniol P; Torelli U
Scand J Clin Lab Invest; 1986 Apr; 46(2):163-6. PubMed ID: 2424075
[TBL] [Abstract][Full Text] [Related]
20. [Substances released by platelets. 1. beta-TG and PF 4].
Niikura H
Rinsho Byori; 1985 Apr; Spec No 62():46-59. PubMed ID: 2411978
[No Abstract] [Full Text] [Related]
[Next] [New Search]
